Advertisement

Lipidomics pp 89-102 | Cite as

Lipid Profiling Using Two-Dimensional Heteronuclear Single Quantum Coherence NMR

  • Engy A. Mahrous
  • Robin B. Lee
  • Richard E. Lee
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 579)

Summary

The use of NMR spectroscopy in lipid research has been traditionally reserved for the analysis and structural elucidation of discrete lipid molecules. Although NMR analysis of organic molecules provides a plethora of structural information that is normally unattainable by most other techniques, its use for global analysis of mixed lipid pools has been hampered by its relatively low sensitivity and overlapping of signals in the spectrum. However, the last few decades have witnessed great advancements in NMR spectroscopy that generally resulted in greater sensitivity and offered more flexibility in sampling techniques. The method discussed in this chapter describes the use of NMR for global lipidome analysis. This methodology benefits from the quantitative nature of this technique together with the abundance of the structural information it can offer, while partially overcoming the problems of low sensitivity and overlapping signals through isotope-enrichment and the use of multidimensional NMR, respectively. We have applied this method successfully to the mycobacterial lipidome as an example of an organism with a very complex and chemically diverse lipid pool. The same concept is applicable to a wide range of prokaryotes that can grow in the laboratory in well-defined growth media.

Key words

NMR spectroscopy Mycobacteria 2D-HSQC Cell wall lipids Polyketides Glycolipids 

Notes

Acknowledgments

We thank Dr Clifton Barry III, (National Institutes of Health) for providing M. tuberculosis HN-878 and HN878-▵D pks strains, Dr. Pamela L.C. Small, (University of Tennessee, Knoxville) for providing both M. marinum and M. liflindii strains, and Dr. Wei Li (University of Tennessee, Memphis) for technical assistance. We acknowledge financial support for this work from National Institutes of Health grant AI076938.

References

  1. 1.
    Goren, M. B., O. Brokl, and W. B. Schaefer. 1974. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: phthiocerol dimycocerosate and the attenuation indicator lipid. Infection and immunity 9:150–158.PubMedGoogle Scholar
  2. 2.
    Goren, M. B., O. Brokl, and W. B. Schaefer. 1974. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: correlation of virulence with elaboration of sulfatides and strongly acidic lipids. Infection and immunity 9:142–149.PubMedGoogle Scholar
  3. 3.
    Kato, M., M. Kusunose, K. Miki, K. Matsunaga, and Y. Yamamura. 1959. The mechanism of the toxicity of cord factor. The American review of respiratory disease 80:240–248.PubMedGoogle Scholar
  4. 4.
    Etemadi, A. H. 1967. [Mycolic acids. Structure, biogenesis and phylogenetic value]. Exposes annuels de biochimie medicale 28:77–109.PubMedGoogle Scholar
  5. 5.
    Etemadi, A. H. 1967. [Structural and biogenetic correlations of mycolic acids in relation to the phylogenesis of various genera of Actinomycetales]. Bulletin de la Societe de chimie biologique 49:695–706.PubMedGoogle Scholar
  6. 6.
    Lechevalier, M. P., A. C. Horan, and H. Lechevalier. 1971. Lipid composition in the classification of nocardiae and mycobacteria. Journal of bacteriology 105:313–318.PubMedGoogle Scholar
  7. 7.
    Minnikin, D. E., L. Alshamaony, and M. Goodfellow. 1975. Differentiation of Mycobacterium, Nocardia, and related taxa by thin-layer chromatographic analysis of whole-organism methanolysates. Journal of general microbiology 88:200–204.PubMedCrossRefGoogle Scholar
  8. 8.
    Dobson, G., D. E. Minnikin, S. M. Minnikin, M. Parlett, M. Goodfellow, M. Ridell, and M. Magnusson. 1985. Systematic analysis of complex mycobacterial lipids. In Chemical methods in bacterial systematics. M. Goodfellow, D. E. Minnikin(eds). Academic, London. 237–2654.Google Scholar
  9. 9.
    Jain, M., C. J. Petzold, M. W. Schelle, M. D. Leavell, J. D. Mougous, C. R. Bertozzi, J. A. Leary, and J. S. Cox. 2007. Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling. Proceedings of the National Academy of Sciences of the United States of America 104:5133–5138.PubMedCrossRefGoogle Scholar
  10. 10.
    Shui, G., A. K. Bendt, K. Pethe, T. Dick, and M. R. Wenk. 2007. Sensitive profiling of chemically diverse bioactive lipids. Journal of lipid research 48:1976–1984.PubMedCrossRefGoogle Scholar
  11. 11.
    Mahrous, E. A., R. B. Lee, and R. E. Lee. 2008. A rapid approach to lipid profiling of mycobacteria using 2D HSQC NMR maps. Journal of lipid research 49:455–463.PubMedCrossRefGoogle Scholar
  12. 12.
    WHO report 2008 Global tuberculosis control surveillance, planning, financing. WHO. 17–20.Google Scholar
  13. 13.
    Brennan, P. J. and H. Nikaido. 1995. The envelope of mycobacteria. Annual review of biochemistry 64:29–63.PubMedCrossRefGoogle Scholar
  14. 14.
    Puzo, G. 1990. The carbohydrate- and lipid-containing cell wall of mycobacteria, phenolic glycolipids: structure and immunological properties. Critical reviews in microbiology 17:305–327.PubMedCrossRefGoogle Scholar
  15. 15.
    Karakousis, P. C., W. R. Bishai, and S. E. Dorman. 2004. Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cellular microbiology 6:105–116.PubMedCrossRefGoogle Scholar
  16. 16.
    Ortalo-Magne, A., A. Lemassu, M. A. Laneelle, F. Bardou, G. Silve, P. Gounon, G. Marchal, and M. Daffe. 1996. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. Journal of bacteriology 178:456–461.PubMedGoogle Scholar
  17. 17.
    Villeneuve, C., G. Etienne, V. Abadie, H. Montrozier, C. Bordier, F. Laval, M. Daffe, I. Maridonneau-Parini, and C. Astarie-Dequeker. 2003. Surface-exposed glycopeptidolipids of Mycobacterium smegmatis specifically inhibit the phagocytosis of mycobacteria by human macrophages. Identification of a novel family of glycopeptidolipids. The Journal of biological chemistry 278:51291–51300.PubMedCrossRefGoogle Scholar
  18. 18.
    Villeneuve, C., M. Gilleron, I. Maridonneau-Parini, M. Daffe, C. Astarie-Dequeker, and G. Etienne. 2005. Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process. Journal of lipid research 46:475–483.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Engy A. Mahrous
    • 1
  • Robin B. Lee
    • 1
  • Richard E. Lee
    • 1
  1. 1.Department of Pharmaceutical Sciences, College of PharmacyUniversity of Tennessee Health Sciences CenterMemphisUSA

Personalised recommendations